Trump Administration Cuts Off Funding for Fetal Tissue Research. Again.

Dr. Jay Bhattacharya, the N.I.H. director, said that the agency will look to make additional investments in “validated emerging technologies” that could “reduce or potentially replace reliance on human embryonic stem cells.”